Restrictive antibiotic policies - How effective are they?

Hospital Pharmacist

Volumn 7, Issue 7, 2000, Pages 183-187

  Binyon, D ^a   Cooke, R P D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AVOPARCIN; MACROLIDE; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; CLOSTRIDIUM DIFFICILE; DRUG COST; DRUG MONITORING; ESCHERICHIA COLI; HAND WASHING; HEALTH CARE POLICY; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MEDICAL AUDIT; MEDICAL STAFF; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PHARMACIST; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; REVIEW; SHIGELLA; STAFF TRAINING; STAPHYLOCOCCUS AUREUS;

EID: 0033834856     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. A review of the role of antibiotic policies in the control of antibiotic resistance
2. Audit of antibiotic usage in a medium-sized general hospital over an 11-year period
3. Working Party of British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK
4. Antimicrobial agent resistance in mycobacteria: Molecular genetic insights
5. Attitudes of house physicians concerning various antibiotic use programs
6. Influence of patient's expectations on antibiotic management of acute lower respiratory tract illness in general practice: Questionnaire study
7. Society for Health care Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
8. Public Health Laboratory Service Meningococcal Infections Working Group and Public Health Medicine Environmental Group Control of meningococcal disease; Guidance for consultants in communicable disease control
9. Working Party of the British Committee for Standards in Haematology Clinical Haematology task force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen
10. Antibacterials for acute otitis media? A review from the international primary care network
11. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project
12. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci
13. The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
14. Patient knowledge of upper respiratory infections: Implications for antibiotic expectations and unnecessary utilization
15. What do patients expect from consultations for upper respiratory tract infections?
16. Strategies for promoting judicious use of antibiotics by doctors and patients
17. Principles of judicious use of antimicrobial agents for paediatric upper respiratory tract infections
18. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
19. Improving drug therapy decisions through educational outreach
20. Principles of educational outreach to improve clinical decision making
21. Feedback of clinical practice information
22. A computer-assisted management programme for antibiotics and other anti-infective agents
23. Do antimicrobials increase the carriage rate of penicillin-resistant pneumococci in children? Cross sectional prevalence study
24. Management of methicillin resistant Staphylococcus aureus in the Netherlands
25. Antimicrobial drug resistance
26. An antibiotic policy to prevent emergence of resistant bacilli
27. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: A lesson from a paediatric institution in a developing country
28. Controlling Clostridium difficile infection by a restrictive antibiotic policy
29. Infectious intestinal disease in elderly people
30. Clostridium difficile in England and Wales: A quarterly report
31. Clostridium difficile: An update on its epidemiology and role in hospital outbreaks in England and Wales
32. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy
33. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus
34. Stewardship of antibiotic use and resistance surveillance: The international scene
35. Preventing the emergence of antimicrobial resistance